Friday, 15 August 2008
New Drug Development In Bladder Cancer: Understanding Biology To Develop Future Leads
�UroToday.com - Chemotherapy is effective in both topically advanced and metastatic vesica cancer. Two randomized trials have demonstrated that preoperative administration of Methotrexate, Vinblastine, Adriamycin, Cisplatin (MVAC) or Cisplatin, Methotrexte,Vinblastine (CMV) better survival in patients with muscle invasive transitional cell carcinoma of the bladder. Other advantages of neoadjuvant therapy include the in vivo monstrance of